Reversal of neurobehavioral and neurochemical alterations in STZ-induced diabetic rats by FeTMPyP, a peroxynitrite decomposition catalyst and 1,5-Isoquinolinediol a poly(ADP-ribose) polymerase inhibitor

Neurological Research

Volumn 36, Issue 7, 2014, Pages 619-626

  Jangra, Ashok ^a   Datusalia, Ashok Kumar ^a   Sharma, Shyam Sunder ^a  

^a NATIONAL INSTITUTE OF PHARMACEUTICAL EDUCATION AND RESEARCH NIPER   (India)

Author keywords

1, 5 isoquinolinediol; Diabetes; FeTMPyP; Nitrosative stress; PARP; Peroxynitrite

Indexed keywords

1,5 ISOQUINOLINEDIOL; 4 AMINOBUTYRIC ACID; ACETYLCHOLINESTERASE; GLUTAMIC ACID; NEUROTRANSMITTER; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE INHIBITOR; PEROXYNITRITE; UNCLASSIFIED DRUG; 1,5-DIHYDROXYISOQUINOLINE; 5,10,15,20-TETRAKIS(N-METHYL-4'-PYRIDYL)PORPHYRINATO-IRON(III); ACHE PROTEIN, RAT; AGENTS INTERACTING WITH TRANSMITTER, HORMONE OR DRUG RECEPTORS; ANTIDIABETIC AGENT; ENZYME INHIBITOR; GLUCOSE BLOOD LEVEL; GLYCOSYLPHOSPHATIDYLINOSITOL ANCHORED PROTEIN; ISOQUINOLINE DERIVATIVE; METALLOPORPHYRIN; NICOTINAMIDE ADENINE DINUCLEOTIDE; PEROXYNITROUS ACID; STREPTOZOCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; COGNITION; CONTROLLED STUDY; EXPERIMENTAL BEHAVIORAL TEST; FUNCTIONAL OBSERVATIONAL BATTERY; GLUCOSE BLOOD LEVEL; LIPID PEROXIDATION; MALE; MOTOR COORDINATION; NITROSATIVE STRESS; NONHUMAN; PASSIVE AVOIDANCE TEST; RAT; STREPTOZOTOCIN-INDUCED DIABETES MELLITUS; ANIMAL; ANTAGONISTS AND INHIBITORS; AVOIDANCE BEHAVIOR; DIABETES MELLITUS, EXPERIMENTAL; DRUG EFFECTS; HIPPOCAMPUS; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; SPRAGUE DAWLEY RAT;

ACETYLCHOLINESTERASE; ANIMALS; AVOIDANCE LEARNING; BLOOD GLUCOSE; BODY WEIGHT; DIABETES MELLITUS, EXPERIMENTAL; ENZYME INHIBITORS; GPI-LINKED PROTEINS; HIPPOCAMPUS; HYPOGLYCEMIC AGENTS; ISOQUINOLINES; LIPID PEROXIDATION; MALE; METALLOPORPHYRINS; NAD; NEUROTRANSMITTER AGENTS; PEROXYNITROUS ACID; POLY(ADP-RIBOSE) POLYMERASES; RATS, SPRAGUE-DAWLEY; STREPTOZOCIN;

EID: 84902952897     PISSN: 01616412     EISSN: 17431328     Source Type: Journal    
DOI: 10.1179/1743132813Y.0000000301     Document Type: Article

References (45)

1. Aragno M, Mastrocola R, Medana C, Restivo F, Catalano MG, Pons N, et al. Up-regulation of advanced glycated products receptors in the brain of diabetic rats is prevented by antioxidant treatment. Endocrinology. 2005;146:5561-7.
2. Biessels GJ, Kappelle AC, Bravenboer B, Erkelens DW, Gispen WH. Cerebral function in diabetes mellitus. Diabetologia. 1994;37:643-50.
3. Aragno M, Parola S, Brignardello E, Mauro A, Tamagno E, Manti R, et al. Dehydroepiandrosterone prevents oxidative injury induced by transient ischemia/reperfusion in the brain of diabetic rats. Diabetes. 2000;49:1924-31.
4. Aragno M, Parola S, Tamagno E, Brignardello E, Manti R, Danni O, et al. Oxidative derangement in rat synaptosomes induced by hyperglycaemia: restorative effect of dehydroepiandrosterone treatment. Biochem Pharmacol. 2000;60:389-95.
5. Mastrocola R, Restivo F, Vercellinatto I, Danni O, Brignardello E, Aragno M, et al. Oxidative and nitrosative stress in brain mitochondria of diabetic rats. J Endocrinol. 2005;187:37-44.
6. Kuhad A, Chopra K. Effect of sesamol on diabetes-associated cognitive decline in rats. Exp Brain Res. 2008;185:411-20.
7. Kuhad A, Sethi R, Chopra K. Lycopene attenuates diabetesassociated cognitive decline in rats. Life Sci. 2008;83:128.
8. Radi R, Peluffo G, Alvarez MN, Naviliat M, Cayota A. Unraveling peroxynitrite formation in biological systems. Free Radic Biol Med. 2001;30:463-88.
9. Marla SS, Lee J, Groves JT. Peroxynitrite rapidly permeates phospholipid membranes. Proc Natl Acad Sci U S A. 1997;94:14243-8.
10. Bartesaghi S, Valez V, Trujillo M, Peluffo G, Romero N, Zhang H, et al. Mechanistic studies of peroxynitrite-mediated tyrosine nitration in membranes using the hydrophobic probe Nt-BOC-L-tyrosine tert-butyl ester. Biochemistry. 2006;45: 6813-25.
11. Szabo C. Multiple pathways of peroxynitrite cytotoxicity. Toxicol Lett. 2003;140:105-12.
12. Szabo C. Roles of poly (ADP-ribose) polymerase activation in the pathogenesis of diabetes mellitus and its complications. Pharmacol Res. 2005;52:60-71.
13. Negi G, Kumar A, Sharma SS. Concurrent targeting of nitrosative stress-PARP pathway corrects functional, behavioral and biochemical deficits in experimental diabetic neuropathy. Biochem Biophys Res Commun. 2010;391:102-6.
14. Irwin S. Comprehensive observational assessment: Ia. A systematic, quantitative procedure for assessing the behavioral and physiologic state of the mouse. Psychopharmacology. 1968;13:222-57.
15. Mattsson JL, Spencer PJ, Albee RR. A performance standard for clinical and functional observational battery examinations of rats. Int J Toxicol. 1996;15:239-54.
16. Sharma SS, Srinivasan SK, Krishnamoorthy S, Kaushal AM, Bansal AK. Preclinical safety pharmacological studies on the amorphous formulation of celecoxib. Arzneim-Forsch. 2011;59: 254-62.
17. Kumar P, Kaundal RK, More S, Sharma SS. Beneficial effects of pioglitazone on cognitive impairment in MPTP model of Parkinson's disease. Behav Brain Res. 2009;197:398-403.
18. Ohkawa H. Assay for lipid peroxide in animal tissue by thiobarbituric acid reaction. Anal Biochem. 1979;95:351-8.
19. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951;193:265-75.
20. Nisselbaum JS, Green S. A simple ultramicro method for determination of pyridine nucleotides in tissues. Anal Biochem. 1969;27:212-7.
21. Negi G, Kumar A, Kaundal RK, Gulati A, Sharma SS. Functional and biochemical evidence indicating beneficial effect of Melatonin and Nicotinamide alone and in combination in experimental diabetic neuropathy. Neuropharmacology. 2010; 58:585-92.
22. Lakshmana MK, Rao S, Dhingra NK, Ravikumar R, Meti BL, Raju TR. Chronic (2) deprenyl administration increases dendritic arborization in CA3 neurons of hippocampus and AChE activity in specific regions of the primate brain. Brain Res. 1998;796:38-44.
23. Rao BSS, Raju TR, Meti BL. Self-stimulation of lateral hypothalamus and ventral tegmentum increases the levels of noradrenaline, dopamine, glutamate, and AChE activity, but not 5-hydroxytryptamine and GABA levels in hippocampus and motor cortex. Neurochem Res. 1998;23:1053-9.
24. Bonnefont-Rousselot D. Glucose and reactive oxygen species. Curr Opin Clin Nutr Metab Care. 2002;5:561-8.
25. Lee AYW, Chung SSM. Contributions of polyol pathway to oxidative stress in diabetic cataract. FASEB J. 1999;13:23-30.
26. Ryle C, Leow CK, Donaghy M. Nonenzymatic glycation of peripheral and central nervous system proteins in experimental diabetes mellitus. Muscle Nerve. 1998;20:577-84.
27. Kumar JS, Menon VP. Effect of diabetes on levels of lipid peroxides and glycolipids in rat brain. Metabolism. 1993;42: 1435-9.
28. Baynes JW, Thorpe SR. Role of oxidative stress in diabetic complications: a new perspective on an old paradigm. Diabetes. 1999;48:1-9.
29. Murray J, Taylor SW, Zhang B, Ghosh SS, Capaldi RA. Oxidative damage to mitochondrial complex I due to peroxynitrite. J Biol Chem. 2003;278:37223-30.
30. Massaad CA, Klann E. Reactive oxygen species in the regulation of synaptic plasticity and memory. Antioxid Redox Signal. 2011;14:2013-54.
31. Sharma SS, Munusamy S, Thiyagarajan M, Kaul CL. Neuroprotective effect of peroxynitrite decomposition catalyst and poly (adenosine diphosphate-ribose) polymerase inhibitor alone and in combination in rats with focal ischemia. J Neurosurg. 2004;101:669-75.
32. Arora M, Kumar A, Kaundal RK, Sharma SS. Amelioration of neurological and biochemical deficits by peroxynitrite decomposition catalysts in experimental diabetic neuropathy. Eur J Pharmacol. 2008;596:77-83.
33. Drel VR, Xu W, Zhang J, Pavlov IA, Shevalye H, Slusher B, et al. Poly (adenosine 5-diphosphate-ribose) polymerase inhibition counteracts multiple manifestations of experimental type 1 diabetic nephropathy. Endocrinology. 2009;150:5273-83.
34. Chaitanya GV, Steven AJ, Babu PP. PARP-1 cleavage fragments: signatures of cell-death proteases in neurodegeneration. Cell Commun Signal. 2010;8:31-41.
35. Kamboj SS, Chopra K, Sandhir R. Neuroprotective effect of N-acetylcysteine in the development of diabetic encephalopathy in streptozotocin-induced diabetes. Metab Brain Dis. 2008;23: 427-43.
36. Sales I, Freitas R, Saldanha G, Souza G, Freitas R. Choline acetyltransferase and acetylcholinesterase activities are reduced in rat striatum and frontal cortex after pilocarpine-induced seizures. Neurosci Lett. 2010;469:81-3.
37. Das A, Rai D, Dikshit M, Palit G, Nath C. Nature of stress: differential effects on brain acetylcholinesterase activity and memory in rats. Life Sci. 2005;77:2299-311.
38. Sandhir R, Julka D, Gill K. Lipoperoxidative damage on lead exposure in rat brain and its implications on membrane bound enzymes. Pharmacol Toxicol. 2009;74:66-71.
39. Ashok kumar N, Pari L, Ramkumar KM. N-Benzoyl-D-phenylalanine attenuates brain acetylcholinesterase in neonatal streptozotocin- diabetic rats. Basic Clin Pharm Toxicol. 2006;99:246-50.
40. Tsakiris S. Effects of l-phenylalanine on acetylcholinesterase and Na(z)/K(z)-ATPase activities in adult and aged rat brain. Mech Ageing Dev. 2001;122:491-501.
41. Riedel G, Reymann KG. Metabotropic glutamate receptors in hippocampal long-term potentiation and learning and memory. Acta Physiol Scand. 1996;157:1-19.
42. Cruz-Morales SE, Quirarte GL, Diaz del Guante MA, Prado- Alcalá RA. Effects of GABA antagonists on inhibitory avoidance. Life Sci. 1993;53:1325-30.
43. Flood JF, Morley JE, Roberts E. Memory-enhancing effects in male mice of pregnenolone and steroids metabolically derived from it. Proc Natl Acad Sci U S A. 1992;89:1567-71.
44. Brioni JD. Role of GABA during the multiple consolidation of memory. Drug Dev Res. 2004;28:3-27.
45. Sickmann HM, Waagepetersen HS, Schousboe A, Benie AJ, Bouman SD. Brain glycogen and its role in supporting glutamate and GABA homeostasis in a type 2 diabetes rat model. Neurochem Int. 2012;60:267-75.